Official websites use .gov
A
.gov
website belongs to an official government organization in the
United States.
Secure .gov websites use HTTPS
A
lock
(
) or
https://
means you’ve safely connected to the .gov website. Share sensitive
information only on official, secure websites.
PubMed ID:
35133671
Public Release Type:
Journal
Publication Year: 2022
Affiliation: Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Division of Pediatric Gastroenterology and Hepatology, Seattle Children's Hospital, University of Washington, Seattle, Washington, USA.; Division of Gastroenterology, Hepatology and Nutrition, Cleveland Clinic, Cleveland, Ohio, USA.; Department of Pediatrics, Feinberg Medical School of Northwestern University, Chicago, Illinois, USA.; Division of Gastroenterology, Hepatology and Nutrition, Texas Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.; Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, St. Louis University, St. Louis, Missouri, USA.; Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Emory University School of Medicine, Children's Healthcare of Atlanta, Atlanta, Georgia, USA.; Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA.; Department of Pediatrics, Feinberg Medical School of Northwestern University, Chicago, Illinois, USA.; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Indiana University School of Medicine/Riley Hospital for Children, Indianapolis, Indiana, USA.; Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.; Department of Internal Medicine, Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University School of Medicine, Richmond, Virginia, USA.; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of California San Diego School of Medicine, La Jolla, California, USA.; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
DOI:
https://doi.org/10.1002/hep.32403
Authors:
Vos Miriam B, Van Natta Mark L, Blondet Niviann M, Dasarathy Srinivasan, Fishbein Mark, Hertel Paula, Jain Ajay K, Karpen Saul J, Lavine Joel E, Mohammad Saeed, Miriel Laura A, Molleston Jean P, Mouzaki Marialena, Sanyal Arun, Sharkey Emily P, Schwimmer Jeffrey B, Tonascia James, Wilson Laura A, Xanthakos Stavra A
Request IDs:
22449
Studies:
Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Database
To date, no pharmacotherapy exists for pediatric NAFLD. Losartan, an angiotensin II receptor blocker, has been proposed as a treatment due to its antifibrotic effects.
